Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children

References

• Foo DG, Alonso S, Chow VT, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007; 9:1299 - 306; http://dx.doi.org/10.1016/j.micinf.2007.06.002; PMID: 17890123
   PubMed Web of Science ®Google Scholar
• McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91 - 107; http://dx.doi.org/10.1111/j.1574-6976.2002.tb00601.x; PMID: 12007645
   PubMed Web of Science ®Google Scholar
• Jee YM, Cheon DS, Kim K, Cho JH, Chung YS, Lee J, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol 2003; 148:1735 - 46; http://dx.doi.org/10.1007/s00705-003-0133-6; PMID: 14505086
   PubMed Web of Science ®Google Scholar
• Chong CY, Chan KP, Shah VA, Ng WY, Lau G, Teo TE, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta paediatr 2003; 92:1163 - 9
   PubMed Web of Science ®Google Scholar
• Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, Tsao KC, et al. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J 2010; 29:1030 - 4; PMID: 20543760
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, et al. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 2002; 46:621 - 7; PMID: 12437029
   PubMed Web of Science ®Google Scholar
• Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al, For the Outbreak Study Group. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 2000; 31:678 - 83; http://dx.doi.org/10.1086/314032; PMID: 11017815
   PubMed Web of Science ®Google Scholar
• Zhu Q, Hao Y, Ma J, Yu S, Wang Y. Surveillance of hand, foot, and mouth disease in mainland China (2008-2009). Biomed Environ Sci 2011; 24:349 - 56; PMID: 22108323
   PubMed Web of Science ®Google Scholar
• Lee BY, Wateska AR, Bailey RR, Tai JH, Bacon KM, Smith KJ. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine. Vaccine 2010; 28:7731 - 6; http://dx.doi.org/10.1016/j.vaccine.2010.09.065; PMID: 20923711
   PubMed Web of Science ®Google Scholar
• Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010; 84:661 - 5; http://dx.doi.org/10.1128/JVI.00999-09; PMID: 19864378
   PubMed Web of Science ®Google Scholar
• Puenpa J, Theamboonlers A, Korkong S, Linsuwanon P, Thongmee C, Chatproedprai S, et al. Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011. Arch Virol 2011; 156:2007 - 13; http://dx.doi.org/10.1007/s00705-011-1098-5; PMID: 21898187
   PubMed Web of Science ®Google Scholar
• Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354:1682 - 6; http://dx.doi.org/10.1016/S0140-6736(99)04434-7; PMID: 10568570
   PubMed Web of Science ®Google Scholar
• Lin YC, Wu CN, Shih SR, Ho MS. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 2002; 20:2485 - 93; http://dx.doi.org/10.1016/S0264-410X(02)00182-2; PMID: 12057603
   PubMed Web of Science ®Google Scholar
• Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, et al. EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine 2010; 28:3516 - 21; http://dx.doi.org/10.1016/j.vaccine.2010.03.003; PMID: 20304038
   PubMed Web of Science ®Google Scholar
• Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, et al. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One 2011; 6:e20005; http://dx.doi.org/10.1371/journal.pone.0020005; PMID: 21603631
   PubMed Web of Science ®Google Scholar
• Wu TC, Wang YF, Lee YP, Wang JR, Liu CC, Wang SM, et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol 2007; 81:10310 - 5; http://dx.doi.org/10.1128/JVI.00372-07; PMID: 17626076
   PubMed Web of Science ®Google Scholar
• Fisch A, Cadilhac P, Vidor E, Prazuck T, Dublanchet A, Lafaix C. Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route. Vaccine 1996; 14:1132 - 6; http://dx.doi.org/10.1016/0264-410X(96)00044-8; PMID: 8911009
   PubMed Web of Science ®Google Scholar
• Wiedermann G, Ambrosch F, Kollaritsch H, Hofmann H, Kunz C, D’Hondt E, et al. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine 1990; 8:581 - 4; http://dx.doi.org/10.1016/0264-410X(90)90013-C; PMID: 1965077
   PubMed Web of Science ®Google Scholar
• Wang JF, Guo YS, Christakos G, Yang WZ, Liao YL, Li ZJ, et al. Hand, foot and mouth disease: spatiotemporal transmission and climate. Int J Health Geogr 2011; 10:25; http://dx.doi.org/10.1186/1476-072X-10-25; PMID: 21466689
   PubMed Web of Science ®Google Scholar
• Choi CS, Choi YJ, Choi UY, Han JW, Jeong DC, Kim HH, et al. Clinical manifestations of CNS infections caused by enterovirus type 71. Korean J Pediatr 2011; 54:11 - 6; http://dx.doi.org/10.3345/kjp.2011.54.1.11; PMID: 21359055
   PubMedGoogle Scholar
• Le VT, Phan TQ, Do QH, Nguyen BH, Lam QB, Bach VC, et al. Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl Trop Dis 2010; 4:e854; http://dx.doi.org/10.1371/journal.pntd.0000854; PMID: 21049060
   PubMed Web of Science ®Google Scholar
• The standard guidelines for adverse reactions grading of Vaccine clinical trials. http:// www. sda. gov.cn/WS01/CL0844/9350_5.html., 2005.
   Google Scholar